Skip to content Skip to sidebar Skip to footer

Wall Street finished Wednesday essentially unchanged, as a hotter‑than‑expected January jobs report lifted Treasury yields and tempered hopes for imminent Fed rate cuts, leaving the major indexes little moved by the close. in

Index performance

  • Dow Jones Industrial Average: Fell roughly 70 points (about 0.1%), snapping a three‑day record streak and closing near 50,100.
  • S&P 500: Ended flat on the day around 6,941, effectively unchanged in point terms.
  • Nasdaq Composite: Slipped about 0.2%, closing near 23,060 as weakness in large‑cap tech and software outweighed early gains.

Macro and Fed narrative

  • January jobs: The U.S. economy added about 130,000 jobs in January, the strongest gain in months and above many forecasts, while unemployment edged lower, signaling resilient labor demand.
  • Market reaction: Stronger hiring prompted traders to dial back the odds and magnitude of near‑term Fed rate cuts, with futures increasingly pointing to the first 25‑bp move around June rather than spring.
  • Yields: The 2‑year Treasury yield climbed to roughly 3.5% and the 10‑year pushed above 4.1%, reflecting expectations that policy will stay restrictive for longer.

Sector and stock movers

  • Tech and software: Mega‑cap tech was mixed, but software again came under pressure as investors reassessed growth names seen as vulnerable to AI disruption; names such as ServiceNow, Datadog, Salesforce, and Intuit slid 4–6%, and a major software ETF dropped about 3%.
  • Financials and small caps: Rate‑sensitive financials, including large banks, fell around 1–2%, while the Russell 2000 lagged, down about 0.7%, as higher yields weighed on funding‑sensitive and domestically focused names.
  • Energy and defensives: Energy outperformed, with integrated majors catching a bid as investors rotated toward cash‑generative, dividend‑oriented pockets of the market; some defensive corners of the market also saw relative support.
  • Notable single names: Robinhood slid nearly 9% after its latest earnings disappointed investors, while Generac jumped around 17% on strong quarterly results, topping the S&P 500 leaderboard. Selected AI‑linked and chip names saw intraday strength but gave back part of those gains into the close as rate concerns resurfaced.

Broader market tone

  • Volatility and breadth: Intraday action was choppy, with early gains reversing as yields climbed; declining issues modestly outpaced advancers on both the NYSE and Nasdaq, and new highs continued to outnumber new lows despite the flat headline finish.
  • Positioning: After a powerful run that pushed the Dow to repeated records, today’s session looked like a pause for risk assets as investors digested the idea of “higher for longer” and weighed still‑solid growth against a slower easing path from the Fed.

VP Watchlist

  • Eupraxia Pharmaceuticals (NASDAQ: EPRX) – Shares continue to consolidate after a strong multi‑month advance, with analysts still modeling meaningful upside as the company advances its EP‑104 program and heads toward key 2026 readouts.
  • Modular Medical (NASDAQ: MODD)
    Modular is a leader in innovative insulin delivery technology targeting the $3 billion adult “almost-pumpers” diabetes market with user-friendly, affordable patch pumps
    On Feb. 4, Modular Medical, Inc. announced the start of production of validation lots for its Pivot™ tubeless patch pump’s disposable cartridge and infusion set. Achievement of this critical manufacturing milestone keeps the Company on schedule for commercial launch in Q1 2026, subject to receipt of FDA 510(k) clearance. The Pivot system – the industry’s first removable, tubeless 3ml patch pump – is designed for simplicity and affordability, addressing barriers that prevent many patients from adopting traditional pumps.
  • GeoVax Labs, Inc. (NASDAQ: GOVX) – is a clinical-stage biotechnology company developing multi-antigen vaccines and immunotherapies for infectious diseases and cancer. On Jan. 20, GeoVax announced an update with the following key milestones for 2026 for Geo-MVA:
    Initiation of the pivotal Phase 3 immunobridging trial, expected in the second half of 2026. Continued engagement with European and global health authorities seeking to diversify Mpox and smallpox vaccine supply in light of ongoing global demand pressures
    Advancement toward a U.S.-sourced vaccine supply model addressing both civilian public health needs and biodefense preparedness
  • flyExclusive, Inc. (NYSE American: FLYX) – FLYX is trading in the mid‑$2s as the company leans on at‑the‑market equity to support growth in its private‑jet platform, with shares up solidly year‑to‑date but sentiment still constrained by dilution risk and heavier short interest across the charter space.
  • DoubleVerify Holdings Inc. (NYSE: DV) – DV is hovering in the high‑single‑digit range after a reset in expectations, with recent filings showing a large public pension sharply trimming its stake even as Wall Street’s longer‑term view remains constructive, supported by a small‑cap ad‑verification franchise and a still‑bullish consensus target.
  • The InterGroup Corporation (NASDAQ: INTG) – INTG trades just under $30 with modest liquidity, reflecting its status as a thinly traded real‑estate and hotel holding company whose moves tend to be more idiosyncratic and balance‑sheet‑driven than tied to daily index flows.
  • Serina Therapeutics (NYSE American: SER) – SER remains a high‑beta story: the FDA’s recent acceptance of the SER‑252 IND for advanced Parkinson’s has been a major upside catalyst.
  • Volato Group, Inc. (NYSE American: SOAR) and M2i Global, Inc. (MTWO) – SOAR has staged a sharp near‑term rebound but continues to screen as a very high‑risk, high‑volatility micro‑cap, while MTWO trades in the low‑pennies and remains in a pronounced downtrend as both companies push toward closing their all‑stock critical‑minerals business combination and shareholders prepare to vote on the proposed merger later this month.

Sources
[1] Stock Market News From Feb. 11, 2026: Dow, Nasdaq Fall – Barron’s https://www.barrons.com/livecoverage/stock-market-news-today-021126
[2] Stock Market Today, Feb. 11: S&P 500 Flatlines as Strong Jobs Data … https://finance.yahoo.com/news/stock-market-today-feb-11-231625948.html
[3] S&P 500, Dow muted after jobs data; Alphabet, Microsoft drag on … https://mecktimes.com/news/2026/02/11/s-alphabet-microsoft-drag-on-nasdaq/
[4] Stocks have turned volatile despite strong January jobs report … https://www.morningstar.com/news/marketwatch/20260211259/stocks-have-turned-volatile-despite-strong-january-jobs-report-heres-why-investors-arent-happy
[5] Wall Street ends muted after strong jobs data nibbles at Fed rate cut … https://www.reuters.com/business/us-stock-futures-pause-ahead-january-employment-data-2026-02-11/
[6] Dow Jones Industrial Average (.DJI) – Facebook https://www.facebook.com/texassportstalk.net/posts/heres-todays-stock-market-update-wednesday-february-11th-2026-brought-to-you-by-/1210117287962402/
[7] Dow falls from all-time high, Nasdaq and S&P 500 see back-to-back … https://www.marketwatch.com/livecoverage/stock-market-today-dow-new-record-sp500-nasdaq-up-jobs-report-cisco-earnings
[8] Dow, S&P 500 and Nasdaq Close Lower as Wall Street Ends … https://www.nbcpalmsprings.com/2026/02/11/dow-sp-500-and-nasdaq-close-lower-as-wall-street-ends-wednesday-in-the-red
[9] Markets News, Feb. 11, 2026: Major Indexes Close Lower After Stronger-Than-Expected January Jobs Report, Earnings Flurry https://www.investopedia.com/stock-market-today-dow-jones-s-and-p-500-02112026-11904254
[10] Jobs report lands with surprising 130,000 positions added to US economy last month https://uk.news.yahoo.com/jobs-report-shows-weak-growth-133108760.html
[11] Mixed Economic Signals Complicate Fed Rate‑Cut Path https://www.investing.com/analysis/mixed-economic-signals-complicate-fed-ratecut-path-200674763

Your Guide To Staying Informed In The Markets

Subscribe For Free Email Updates Access To Exclusive Research

Vista Partners — © 2026 — Vista Partners LLC (“Vista”) is a Registered Investment Advisor in the State of California. Vista is not licensed as a broker, broker-dealer, market maker, investment banker, or underwriter in any jurisdiction. By viewing this website and all of its pages, you agree to our terms. Read the full disclaimer here